JP2010505818A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010505818A5 JP2010505818A5 JP2009531012A JP2009531012A JP2010505818A5 JP 2010505818 A5 JP2010505818 A5 JP 2010505818A5 JP 2009531012 A JP2009531012 A JP 2009531012A JP 2009531012 A JP2009531012 A JP 2009531012A JP 2010505818 A5 JP2010505818 A5 JP 2010505818A5
- Authority
- JP
- Japan
- Prior art keywords
- caco
- disease
- chitin
- pharmaceutical formulation
- disorders
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229920002101 Chitin Polymers 0.000 claims 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 8
- 201000010099 disease Diseases 0.000 claims 7
- 239000008194 pharmaceutical composition Substances 0.000 claims 7
- 239000000203 mixture Substances 0.000 claims 6
- 239000000825 pharmaceutical preparation Substances 0.000 claims 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 5
- 238000000034 method Methods 0.000 claims 4
- 239000000126 substance Substances 0.000 claims 4
- 208000002193 Pain Diseases 0.000 claims 3
- 239000006185 dispersion Substances 0.000 claims 3
- 206010004542 Bezoar Diseases 0.000 claims 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims 2
- 201000009030 Carcinoma Diseases 0.000 claims 2
- 241000238424 Crustacea Species 0.000 claims 2
- 229920001184 polypeptide Polymers 0.000 claims 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims 2
- 230000002062 proliferating effect Effects 0.000 claims 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 claims 2
- 208000024827 Alzheimer disease Diseases 0.000 claims 1
- 241000238017 Astacoidea Species 0.000 claims 1
- 208000010392 Bone Fractures Diseases 0.000 claims 1
- 208000020084 Bone disease Diseases 0.000 claims 1
- 206010006187 Breast cancer Diseases 0.000 claims 1
- 208000026310 Breast neoplasm Diseases 0.000 claims 1
- 206010058019 Cancer Pain Diseases 0.000 claims 1
- 208000024172 Cardiovascular disease Diseases 0.000 claims 1
- 206010012289 Dementia Diseases 0.000 claims 1
- 208000016192 Demyelinating disease Diseases 0.000 claims 1
- 208000018035 Dental disease Diseases 0.000 claims 1
- 208000019693 Lung disease Diseases 0.000 claims 1
- 206010025323 Lymphomas Diseases 0.000 claims 1
- 208000016285 Movement disease Diseases 0.000 claims 1
- 208000023178 Musculoskeletal disease Diseases 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 208000012902 Nervous system disease Diseases 0.000 claims 1
- 208000025966 Neurological disease Diseases 0.000 claims 1
- 208000001132 Osteoporosis Diseases 0.000 claims 1
- 208000018737 Parkinson disease Diseases 0.000 claims 1
- 208000004550 Postoperative Pain Diseases 0.000 claims 1
- 206010039491 Sarcoma Diseases 0.000 claims 1
- 208000027418 Wounds and injury Diseases 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 208000015322 bone marrow disease Diseases 0.000 claims 1
- 208000003362 bronchogenic carcinoma Diseases 0.000 claims 1
- 229910000019 calcium carbonate Inorganic materials 0.000 claims 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 claims 1
- 239000000920 calcium hydroxide Substances 0.000 claims 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 claims 1
- 230000003913 calcium metabolism Effects 0.000 claims 1
- 230000028956 calcium-mediated signaling Effects 0.000 claims 1
- 239000001569 carbon dioxide Substances 0.000 claims 1
- 229910002092 carbon dioxide Inorganic materials 0.000 claims 1
- 230000010261 cell growth Effects 0.000 claims 1
- 208000035475 disorder Diseases 0.000 claims 1
- 208000026278 immune system disease Diseases 0.000 claims 1
- 230000001939 inductive effect Effects 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 208000014674 injury Diseases 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 201000001441 melanoma Diseases 0.000 claims 1
- 238000012544 monitoring process Methods 0.000 claims 1
- 201000006417 multiple sclerosis Diseases 0.000 claims 1
- 208000004296 neuralgia Diseases 0.000 claims 1
- 208000015122 neurodegenerative disease Diseases 0.000 claims 1
- 208000021722 neuropathic pain Diseases 0.000 claims 1
- 201000001119 neuropathy Diseases 0.000 claims 1
- 230000007823 neuropathy Effects 0.000 claims 1
- 208000030212 nutrition disease Diseases 0.000 claims 1
- 239000011368 organic material Substances 0.000 claims 1
- 208000033808 peripheral neuropathy Diseases 0.000 claims 1
- 229910000160 potassium phosphate Inorganic materials 0.000 claims 1
- 235000011009 potassium phosphates Nutrition 0.000 claims 1
- 239000002244 precipitate Substances 0.000 claims 1
- 230000001850 reproductive effect Effects 0.000 claims 1
- 230000000717 retained effect Effects 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 238000009738 saturating Methods 0.000 claims 1
- 239000001488 sodium phosphate Substances 0.000 claims 1
- 229910000162 sodium phosphate Inorganic materials 0.000 claims 1
- 239000006228 supernatant Substances 0.000 claims 1
- 239000000725 suspension Substances 0.000 claims 1
- 208000024891 symptom Diseases 0.000 claims 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL178495A IL178495A (en) | 2006-10-05 | 2006-10-05 | Use of cancerous gastric components or artificial calcium containing carbonate, chitin and polypeptide preparations to treat calcium metabolism-related or calcium-signaling conditions |
| PCT/IL2007/001211 WO2008041236A2 (en) | 2006-10-05 | 2007-10-07 | Composition comprising crustacean gastrolith components, calcium carbonate and its use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010505818A JP2010505818A (ja) | 2010-02-25 |
| JP2010505818A5 true JP2010505818A5 (https=) | 2010-11-18 |
Family
ID=39153987
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009531012A Pending JP2010505818A (ja) | 2006-10-05 | 2007-10-07 | 甲殻類の胃石成分を含む組成物とその使用 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US20100098774A1 (https=) |
| EP (1) | EP2068891B1 (https=) |
| JP (1) | JP2010505818A (https=) |
| CN (1) | CN101563091A (https=) |
| AU (1) | AU2007303786B2 (https=) |
| CA (1) | CA2665141C (https=) |
| CY (1) | CY1114930T1 (https=) |
| DK (1) | DK2068891T3 (https=) |
| ES (1) | ES2439741T3 (https=) |
| IL (1) | IL178495A (https=) |
| PL (1) | PL2068891T3 (https=) |
| PT (1) | PT2068891E (https=) |
| SI (1) | SI2068891T1 (https=) |
| WO (1) | WO2008041236A2 (https=) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8257750B2 (en) * | 1999-04-30 | 2012-09-04 | Kibow Biotech, Inc. | Calcium carbonate compositions for preventing or treating hyperphosphatemia |
| PL2211873T3 (pl) | 2007-10-22 | 2013-01-31 | Amorphical Ltd | Stabilny amorficzny węglan wapnia wchodzący w skład fosforylowanych aminokwasów |
| EP2790710B1 (en) | 2011-12-13 | 2020-08-26 | Amorphical Ltd. | Amorphous calcium carbonate for the treatment of calcium malabsorption and metabolic bone disorders |
| WO2014024191A1 (en) | 2012-08-07 | 2014-02-13 | Amorphical Ltd. | Method for producing stabilized amorphous calcium carbonate |
| JP2016507553A (ja) * | 2013-02-11 | 2016-03-10 | アモーフィカル リミテッド． | 骨成長を促進する非晶質炭酸カルシウム |
| CN103417635B (zh) * | 2013-08-15 | 2015-05-20 | 张荣惠 | 接骨药 |
| EP3174409A4 (en) | 2014-07-31 | 2018-01-17 | Amorphical Ltd. | Encapsulated amorphous calcium carbonate compositions |
| US12121538B2 (en) | 2015-06-04 | 2024-10-22 | Amorphical Ltd. | Compositions of amorphous calcium carbonate for inhalation, sublingual or buccal administration |
| HK1253702A1 (zh) * | 2015-06-04 | 2019-06-28 | 艾玛菲克有限公司 | 用聚磷酸/聚磷酸酯/聚磷酸盐或双膦酸/双膦酸酯/双膦酸盐稳定的无定形碳酸钙 |
| AU2016374162A1 (en) * | 2015-12-14 | 2018-04-19 | Nestec S.A. | Nutritional compositions and infant formulas to promote myelination in the brain |
| MY197734A (en) * | 2015-12-14 | 2023-07-12 | Nestle Sa | Nutritional compositions and infant formula for promoting de novo myealination |
| US11478011B2 (en) | 2015-12-14 | 2022-10-25 | Societe Des Produits Nestle S.A. | Nutritional compositions and infant formula for promoting de novo myealination |
| JP6873389B2 (ja) | 2016-01-18 | 2021-05-19 | アモーフィカル リミテッド． | 神経学的、筋肉、および不妊の疾患または症状の治療のための安定化無定形炭酸カルシウム |
| ES3052833T3 (en) | 2016-01-18 | 2026-01-15 | Amorphical Ltd | Stabilized amorphous calcium carbonate as a supplement for cell culture media |
| JP7152785B2 (ja) * | 2016-10-25 | 2022-10-13 | アモーフィカル リミテッド． | 白血病治療のための非晶質炭酸カルシウム |
| IL289237B2 (en) | 2019-07-23 | 2026-03-01 | Amorphical Ltd | Amorphous calcium carbonate for improving athletic performance |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4237147A (en) | 1974-01-04 | 1980-12-02 | Monsanto Company | Stabilized amorphous calcium carbonate |
| US4199496A (en) * | 1974-09-05 | 1980-04-22 | Johnson Edwin L | Process for the recovery of chemicals from the shells of crustacea |
| US5886012A (en) * | 1989-03-22 | 1999-03-23 | Peter K. T. Pang | Method of treatment for disease associated with excessive PHF using combination therapy involving exogenous calcium and calcium channel blockers |
| US20060165784A1 (en) * | 1997-05-06 | 2006-07-27 | Zhao Jin R | Calcium supplement |
| US20030077604A1 (en) * | 2000-10-27 | 2003-04-24 | Yongming Sun | Compositions and methods relating to breast specific genes and proteins |
| JP2002205947A (ja) * | 2000-12-11 | 2002-07-23 | Chafflose Corporation | 水虫治療薬 |
| EP1416916B1 (en) * | 2001-08-16 | 2007-10-17 | Cmp Therapeutics Limited | Chitin microparticles and their medical uses |
| JP2004081739A (ja) * | 2002-08-29 | 2004-03-18 | Mitsuru Akashi | ハイドロキシアパタイト−ポリマー複合材料の止血用組成物 |
| WO2005025581A1 (fr) * | 2003-09-17 | 2005-03-24 | Third Military Medical University, Chinese People's Liberation Army, P.R. Of China | Utilisation de la n-acetyl-d-aminoglycosamine pour la preparation de medicaments de traitement du cancer et des metastases |
| CA2567972C (en) * | 2004-05-26 | 2015-07-28 | Ben-Gurion University Of The Negev Research And Development Authority | Orally-administrable compositions comprising stable amorphous calcium carbonate |
| WO2006043966A2 (en) * | 2004-10-15 | 2006-04-27 | University Of Tennessee Research Foundation | Methods for inducing apoptosis in adipocytes |
-
2006
- 2006-10-05 IL IL178495A patent/IL178495A/en active IP Right Grant
-
2007
- 2007-10-07 SI SI200731375T patent/SI2068891T1/sl unknown
- 2007-10-07 AU AU2007303786A patent/AU2007303786B2/en not_active Ceased
- 2007-10-07 ES ES07827185.5T patent/ES2439741T3/es active Active
- 2007-10-07 JP JP2009531012A patent/JP2010505818A/ja active Pending
- 2007-10-07 PT PT78271855T patent/PT2068891E/pt unknown
- 2007-10-07 US US12/443,987 patent/US20100098774A1/en not_active Abandoned
- 2007-10-07 WO PCT/IL2007/001211 patent/WO2008041236A2/en not_active Ceased
- 2007-10-07 DK DK07827185.5T patent/DK2068891T3/da active
- 2007-10-07 CA CA2665141A patent/CA2665141C/en active Active
- 2007-10-07 PL PL07827185T patent/PL2068891T3/pl unknown
- 2007-10-07 EP EP07827185.5A patent/EP2068891B1/en not_active Not-in-force
- 2007-10-07 CN CNA200780045195XA patent/CN101563091A/zh active Pending
-
2012
- 2012-12-27 US US13/728,508 patent/US8728533B2/en active Active
-
2013
- 2013-12-20 CY CY20131101156T patent/CY1114930T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010505818A5 (https=) | ||
| CA2665141C (en) | Composition comprising crustacean gastrolith components and its use | |
| Trivedi et al. | Physical, thermal, and spectroscopic characterization of biofield energy treated murashige and skoog plant cell culture media | |
| CN105580987B (zh) | 饲料用有机涂敷多孔质颗粒及其制备方法 | |
| CN106219720B (zh) | 改善水质、增强免疫力、有益心脑血管疾病的复合矿物质晶体及其制备方法 | |
| Chaikool | Optimum conditions for preparation of bio-calcium from blood cockle and golden apple snail shells and characterization | |
| KR101896424B1 (ko) | 다공성 미네랄 제조방법 및 이를 이용한 수용화된 다공성 미네랄 조성물 제조방법 | |
| ATE520627T1 (de) | Calcium- und/oder magnesiumhydroxid mit höherer aktivität und seine zubereitung | |
| Zhang et al. | Fabrication of flower-like hydroxyapatite agglomerates with the assistant of bamboo membrane | |
| WO2021005860A1 (ja) | 養殖用資材及びその製造方法 | |
| KR102036125B1 (ko) | 저분자 저밀도 이온화 미네랄 복합체 및 이의 제조방법 | |
| Tan et al. | Water-dispersible hydroxyapatite nanorods synthesized by a facile method | |
| CN102754741A (zh) | 一种补充海参矿物质的饲料及其制备和使用方法 | |
| JPH0745324B2 (ja) | 繊維状炭酸カルシウムの製造方法 | |
| Li et al. | Crystallization of dicalcium phosphate dihydrate with presence of glutamic acid and arginine at 37 C | |
| Xiao et al. | Effect of poly (sodium 4-styrene-sulfonate) on the crystal growth of hydroxyapatite prepared by hydrothermal method | |
| JP2699946B2 (ja) | 麦飯石飼料及びその製法 | |
| KR20180028146A (ko) | 유해성분이 제거된 안정한 법제유황의 제조방법 | |
| TWI882135B (zh) | 由發酵液製備胺基酸顆粒之方法 | |
| KR20020016729A (ko) | 유황과 광물질을 소재로한 오리 사료의 제조방법 및 그조성물 | |
| CN108968075A (zh) | 一种提高骨骼健康的组合物及其应用 | |
| CN107927344A (zh) | 一种功能化营养舔砖及其制备方法 | |
| KR100761896B1 (ko) | 고농도 미네랄 소금 제조방법 | |
| CN108658039A (zh) | 一种水制氢材料及其制备方法和应用 | |
| Pazourková et al. | Preparation of calcium deficient hydroxyapatite on vermiculite from China and Africa deposits |